Stocktoria
ORTHOPEDIATRICS CORP KIDS
ORTHOPEDIATRICS CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236.3M | $204.7M | $148.7M | $122.3M | $98.0M | $71.1M | $72.6M | $57.6M | $45.6M | $37.3M |
| Gross profit | $172.7M | $148.6M | $111.3M | $90.7M | $73.4M | $55.0M | $54.6M | $42.7M | $34.5M | $26.4M |
| R&D expense | $9.1M | $11.0M | $10.9M | $8.5M | $5.5M | $5.3M | $5.7M | $4.7M | $3.4M | $2.2M |
| Operating income | -$39.2M | -$35.0M | -$26.8M | -$25.4M | -$18.0M | -$26.8M | -$9.1M | -$9.6M | -$6.5M | -$6.1M |
| Interest expense | — | — | — | — | — | $3.4M | $3.5M | $2.3M | $2.5M | $1.5M |
| Income tax | $460,000 | -$4.1M | -$338,000 | -$4.9M | -$1.1M | -$723,000 | $0 | $0 | $0 | $0 |
| Net income | -$39.6M | -$37.8M | -$21.0M | $1.3M | -$16.3M | -$32.9M | -$13.7M | -$12.0M | -$8.9M | -$6.6M |
| EPS (diluted) | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 | $-1.82 | $-0.94 | — | — | — |
| Operating cash flow | -$4.9M | -$27.0M | -$27.0M | -$21.8M | -$13.1M | -$18.5M | -$17.8M | -$15.6M | -$7.2M | -$1.1M |
| Free cash flow | -$16.0M | -$41.3M | -$43.9M | -$31.8M | -$21.2M | -$29.0M | -$29.6M | -$20.8M | -$12.4M | -$5.5M |
| Cash & equivalents | $19.6M | $43.8M | $31.1M | $9.0M | $7.6M | $28.8M | $70.8M | $60.7M | $42.6M | $1.6M |
| Inventory | $133.8M | $117.0M | $105.9M | $78.2M | $57.6M | $53.0M | $38.0M | $25.7M | — | — |
| Total assets | $508.6M | $473.2M | $438.7M | $427.7M | $304.3M | $320.4M | $182.2M | $112.1M | $82.3M | $30.7M |
| Total liabilities | $162.0M | $118.6M | $61.7M | $49.1M | $78.9M | $85.6M | $39.8M | $30.4M | $34.8M | $24.7M |
| Shareholders' equity | $346.6M | $354.6M | $377.0M | $378.6M | $225.4M | $234.8M | $142.4M | $81.7M | $47.5M | -$65.3M |
Growth · year-over-year · Revenue CAGR 22.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +15.4% | +37.6% | +21.6% | +24.7% | +37.9% | -2.0% | +26.0% | +26.2% | +22.3% | — |
| Net income growth | — | — | -1767.2% | — | — | — | — | — | — | — |
| EPS growth | — | — | -1633.3% | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.